These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 31131731)
21. Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease. Fletcher EJR; Moon LDF; Duty S BMC Neurosci; 2019 Dec; 20(1):61. PubMed ID: 31862005 [TBL] [Abstract][Full Text] [Related]
23. Protective effect of Nrf2-ARE activator isolated from green perilla leaves on dopaminergic neuronal loss in a Parkinson's disease model. Masaki Y; Izumi Y; Matsumura A; Akaike A; Kume T Eur J Pharmacol; 2017 Mar; 798():26-34. PubMed ID: 28167258 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies. Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751 [TBL] [Abstract][Full Text] [Related]
25. Both Intracranial and Intravenous Administration of Functionalized Carbon Nanotubes Protect Dopaminergic Neuronal Death from 6-Hydroxydopamine. Kim OH; Park JH; Son JI; Kim KY; Lee HJ Int J Nanomedicine; 2020; 15():7615-7626. PubMed ID: 33116491 [TBL] [Abstract][Full Text] [Related]
26. Protective effects of β- nicotinamide adenine dinucleotide against motor deficits and dopaminergic neuronal damage in a mouse model of Parkinson's disease. Shan C; Gong YL; Zhuang QQ; Hou YF; Wang SM; Zhu Q; Huang GR; Tao B; Sun LH; Zhao HY; Li ST; Liu JM Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109670. PubMed ID: 31220519 [TBL] [Abstract][Full Text] [Related]
27. Antioxidant and anti-inflammatory effects of dexrazoxane on dopaminergic neuron degeneration in rodent models of Parkinson's disease. Mei M; Zhou Y; Liu M; Zhao F; Wang C; Ding J; Lu M; Hu G Neuropharmacology; 2019 Dec; 160():107758. PubMed ID: 31494143 [TBL] [Abstract][Full Text] [Related]
28. Edible bird's nest ameliorates oxidative stress-induced apoptosis in SH-SY5Y human neuroblastoma cells. Yew MY; Koh RY; Chye SM; Othman I; Ng KY BMC Complement Altern Med; 2014 Oct; 14():391. PubMed ID: 25308934 [TBL] [Abstract][Full Text] [Related]
29. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease. Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809 [TBL] [Abstract][Full Text] [Related]
30. Grape seed and skin extract as an adjunct to xenical therapy reduces obesity, brain lipotoxicity and oxidative stress in high fat diet fed rats. Mahmoudi M; Charradi K; Limam F; Aouani E Obes Res Clin Pract; 2018; 12(Suppl 2):115-126. PubMed ID: 27161420 [TBL] [Abstract][Full Text] [Related]
31. Dopamine- and Grape-Seed-Extract-Loaded Solid Lipid Nanoparticles: Interaction Studies between Particles and Differentiated SH-SY5Y Neuronal Cell Model of Parkinson's Disease. Mallamaci R; Musarò D; Greco M; Caponio A; Castellani S; Munir A; Guerra L; Damato M; Fracchiolla G; Coppola C; Cardone RA; Rashidi M; Tardugno R; Sergio S; Trapani A; Maffia M Molecules; 2024 Apr; 29(8):. PubMed ID: 38675592 [TBL] [Abstract][Full Text] [Related]
32. Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson's disease. Sarookhani MR; Haghdoost-Yazdi H; Sarbazi-Golezari A; Babayan-Tazehkand A; Rastgoo N Behav Pharmacol; 2018 Jun; 29(4):336-343. PubMed ID: 29239973 [TBL] [Abstract][Full Text] [Related]
33. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase. Mori MA; Delattre AM; Carabelli B; Pudell C; Bortolanza M; Staziaki PV; Visentainer JV; Montanher PF; Del Bel EA; Ferraz AC Nutr Neurosci; 2018 Jun; 21(5):341-351. PubMed ID: 28221817 [TBL] [Abstract][Full Text] [Related]
34. Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson's disease. Khan MM; Raza SS; Javed H; Ahmad A; Khan A; Islam F; Safhi MM; Islam F Neurotox Res; 2012 Jul; 22(1):1-15. PubMed ID: 22194158 [TBL] [Abstract][Full Text] [Related]
35. Anti-oxidant polydatin (piceid) protects against substantia nigral motor degeneration in multiple rodent models of Parkinson's disease. Chen Y; Zhang DQ; Liao Z; Wang B; Gong S; Wang C; Zhang MZ; Wang GH; Cai H; Liao FF; Xu JP Mol Neurodegener; 2015 Mar; 10():4. PubMed ID: 26013581 [TBL] [Abstract][Full Text] [Related]
36. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease. Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060 [TBL] [Abstract][Full Text] [Related]
37. Protective Mechanisms of Flavonoids in Parkinson's Disease. Magalingam KB; Radhakrishnan AK; Haleagrahara N Oxid Med Cell Longev; 2015; 2015():314560. PubMed ID: 26576219 [TBL] [Abstract][Full Text] [Related]
38. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model. Li H; Park G; Bae N; Kim J; Oh MS; Yang HO J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210 [TBL] [Abstract][Full Text] [Related]
39. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
40. Troxerutin exerts neuroprotection in 6-hydroxydopamine lesion rat model of Parkinson's disease: Possible involvement of PI3K/ERβ signaling. Baluchnejadmojarad T; Jamali-Raeufy N; Zabihnejad S; Rabiee N; Roghani M Eur J Pharmacol; 2017 Apr; 801():72-78. PubMed ID: 28284752 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]